Targeting the Endothelin A Receptor in IgA Nephropathy

Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis worldwide and carries a substantial risk of kidney failure. New agency-approved therapies, either specifically for IgAN or for chronic kidney disease (CKD) in general, hold out hope for mitigating renal deterioration i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kohan, Donald E., Barratt, Jonathan, Heerspink, Hiddo J.L., Campbell, Kirk N., Camargo, Mariannne, Ogbaa, Ike, Haile-Meskale, Ruth, Rizk, Dana V., King, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658204/
https://www.ncbi.nlm.nih.gov/pubmed/38025243
http://dx.doi.org/10.1016/j.ekir.2023.07.023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658204/
https://www.ncbi.nlm.nih.gov/pubmed/38025243
http://dx.doi.org/10.1016/j.ekir.2023.07.023

Ejemplares similares